These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [ON THE PROBLEMS OF BLOOD TRANSFUSION (FROM THE STANDPOINT OF THE DEPARTMENT OF PUBLIC WELFARE)]. YAMAGATA S Rinsho Geka; 1964 Oct; 19():1347-8. PubMed ID: 14220920 [No Abstract] [Full Text] [Related]
4. [MEASURES FOR THE PREVENTION OF HEPATITIS AFTER BLOOD TRANSFUSION; SUPERVISION OF BLOOD DONORS]. MURAKAMI S Naika; 1964 Jul; 14():65-70. PubMed ID: 14174358 [No Abstract] [Full Text] [Related]
5. [CLINICAL PROGRESS IN HEPATITIS AFTER BLOOD TRANSFUSION]. KOSAKA K Naika; 1964 Jul; 14():48-51. PubMed ID: 14174355 [No Abstract] [Full Text] [Related]
6. [TRANSFUSIONS AND TRANSFUSION CENTERS]. ROSSI G Arcisp S Anna Ferrara; 1963; 16():837-51. PubMed ID: 14122193 [No Abstract] [Full Text] [Related]
7. [VALUE OF TRANSAMINASE DETERMINATION IN DONOR BLOOD IN THE PREVENTION OF HEPATITIS THROUGH TRANSFUSION]. BRANDT KH; MEULENDIJK PN; POULIE NJ; SCHALM L; SCHULTE MJ; ZANEN HC Ned Tijdschr Geneeskd; 1963 Dec; 107():2312-9. PubMed ID: 14102353 [No Abstract] [Full Text] [Related]
8. TRANSMISSION OF HEPATITIS BY BLOOD AND BLOOD PRODUCTS. MAYCOCK WD Proc R Soc Med; 1964 Nov; 57(11):1077-80. PubMed ID: 14226771 [No Abstract] [Full Text] [Related]
9. VIRAL HEPATITIS IN A GROUP OF BOSTON HOSPITALS. I. A RETROSPECTIVE STUDY OF 1675 PATIENTS. GRADY GF; CHALMERS TC N Engl J Med; 1965 Apr; 272():657-61. PubMed ID: 14257838 [No Abstract] [Full Text] [Related]
10. VIRAL HEPATITIS IN A GROUP OF BOSTON HOSPITALS. II. A PROSPECTICE CONTROLLED EPIDEMIOLOGIC STUDY. GRADY GF; CHALMERS TC N Engl J Med; 1965 Apr; 272():662-6. PubMed ID: 14257839 [No Abstract] [Full Text] [Related]
11. [Search for the Australia antigen in donors at the Liège blood transfusion center]. Brocteur J; Otto-Servais M; André A Rev Med Liege; 1971 Jul; 26(13):437-42. PubMed ID: 4997973 [No Abstract] [Full Text] [Related]
12. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing. Murokawa H; Yoshikawa A; Ohnuma H; Iwata A; Katoh N; Miyamoto M; Mine H; Emura H; Tadokoro K; Vox Sang; 2005 Jan; 88(1):10-6. PubMed ID: 15663717 [TBL] [Abstract][Full Text] [Related]
13. [Australia antigen and viral hepatitis. Epidemiological study in blood donors]. Mansueto S; Tedesco V; Migneco G G Mal Infett Parassit; 1971 Dec; 23(12):1137-40. PubMed ID: 5004898 [No Abstract] [Full Text] [Related]
15. Hepatitis-associated antigen in Belgium. Desmyter J; Liu W Arch Belg Med Soc; 1971 Jan; 29(1):1-10. PubMed ID: 5095938 [No Abstract] [Full Text] [Related]
16. [Prevention of transmission of viral hepatitis by blood derivatives by regular screening for Australia antigen (Au-HAA)]. Novák J; Urbánková J Cas Lek Cesk; 1972; 111(18):409-12. PubMed ID: 5023513 [No Abstract] [Full Text] [Related]
17. A prospective study of posttransfusion hepatitis. The role of Australia Antigen. Gocke DJ JAMA; 1972 Feb; 219(9):1165-70. PubMed ID: 5066869 [No Abstract] [Full Text] [Related]